Overview

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

Status:
Terminated

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

This is a randomized trial to compare intermittent compression devices with or without post-operative Arixtra (fondaparinux sodium) in women undergoing major abdominal surgery for known or presumed gynecologic malignancies. This trial seeks to determine if there is a difference in the rate of deep venous thrombosis between these two groups.

Phase:

Phase 3

Details

Lead Sponsor:

University of Alabama at Birmingham

Collaborator:

GlaxoSmithKline

Treatments:

Fondaparinux
PENTA